Hashimoto, Takafumi
Osoegawa, Atsushi
Abe, Miyuki
Oki, Ryoko
Karashima, Takashi
Takumi, Yohei
Kamada, Kosuke
Miyawaki, Michiyo
Sugio, Kenji
Funding for this research was provided by:
Oita University
Article History
Received: 15 August 2023
Accepted: 28 December 2023
First Online: 6 March 2024
Declarations
:
: Dr. Sugio reports receiving research funding from Eli Lilly, Chugai, Boehringer Ingelheim, and Covidien Japan. Dr. Osoegawa reports receiving research funding from Astra Zeneca, Ono, MSD, Eli Lilly, Chugai, Boehringer Ingelheim, Bristol Meyers Squibb, Ethicon, and Medtronic. The remaining authors declare no conflict of interest.
: Research involving human participants and/or animals. For this type of study formal consent is not required. The patient in this report was provided written informed consent of publication of details of this therapy for use in research purpose.